Identification of a Novel c-Myc Inhibitor 7594-0037 by Structure-Based Virtual Screening and Investigation of Its Anti-Cancer Effect on Multiple Myeloma
Ruosi Yao,1,2 Yu Xie,1 Xiaoyang Sun,1 Menghui Zhang,1 Jian Zhou,1 Linlin Liu,3 Jian Gao,4 Kailin Xu1,2 1Blood Diseases Institute, Xuzhou Medical University, Xuzhou, Jiangsu, People’s Republic of China; 2Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou,...
Saved in:
Main Authors: | Yao R (Author), Xie Y (Author), Sun X (Author), Zhang M (Author), Zhou J (Author), Liu L (Author), Gao J (Author), Xu K (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Investigation of the Underlying Mechanism of Sclerosteosis Expression in Muscle Tissue in Multiple Myeloma with Sarcopenia
by: Ren J, et al.
Published: (2023) -
Multiple myeloma and the potential of new checkpoint inhibitors for immunotherapy
by: Ali N. Kamali, et al.
Published: (2024) -
Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma
by: Noah M. Merin, et al.
Published: (2014) -
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
by: Domenico Ribatti
Published: (2010) -
SHP2 Inhibitors Show Anti-Myeloma Activity and Synergize With Bortezomib in the Treatment of Multiple Myeloma
by: Pan Zhou, et al.
Published: (2022)